Sciencast Management’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $278K | Buy |
4,149
+1,003
| +32% | +$67.2K | 0.06% | 326 |
|
|
2022
Q1 | $263K | Sell |
3,146
-7,548
| -71% | -$631K | 0.06% | 333 |
|
|
2021
Q4 | $802K | Buy |
10,694
+8,293
| +345% | +$622K | 0.14% | 204 |
|
|
2021
Q3 | $265K | Buy |
+2,401
| New | +$265K | 0.08% | 301 |
|
|
2021
Q2 | – | Sell |
-8,575
| Closed | -$1.14M | – | 628 |
|
|
2021
Q1 | $1.14M | Buy |
+8,575
| New | +$1.14M | 0.23% | 134 |
|
|
2020
Q4 | – | Sell |
-4,650
| Closed | -$622K | – | 578 |
|
|
2020
Q3 | $622K | Sell |
4,650
-5,450
| -54% | -$729K | 0.24% | 137 |
|
|
2020
Q2 | $582K | Buy |
+10,100
| New | +$582K | 0.15% | 235 |
|
|
2020
Q1 | – | Sell |
-7,517
| Closed | -$596K | – | 494 |
|
|
2019
Q4 | $596K | Buy |
+7,517
| New | +$596K | 0.16% | 210 |
|